A5086933178- Syphilis Diagnosis and Treatment
- Women's cancer prevention and management
- SARS-CoV-2 and COVID-19 Research
- Medical Coding and Health Information
- HIV/AIDS Impact and Responses
- Focus Groups and Qualitative Methods
- Health, Nursing, Elderly Care
- Data-Driven Disease Surveillance
- Immune responses and vaccinations
- Cancer Immunotherapy and Biomarkers
- Global Public Health Policies and Epidemiology
- COVID-19 Clinical Research Studies
- Vaccine Coverage and Hesitancy
Universidade Federal do Rio Grande do Norte
2022-2023
Hospital Universitário Onofre Lopes
2023
Syphilis is a sexually transmitted disease (STD) caused by Treponema pallidum subspecies pallidum. In 2016, it was declared an epidemic in Brazil due to its high morbidity and mortality rates, mainly cases of maternal syphilis (MS) congenital (CS) with unfavorable outcomes. This paper aimed mathematically describe the relationship between MS CS reported over interval from 2010 2020, considering likelihood diagnosis effective timely treatment during prenatal care, thus supporting...
With syphilis cases on the rise, Brazil declared an epidemic in 2016. To address consequent public health crisis, Ministry of Health laid out a rapid response plan, namely, "Syphilis No!" Project (SNP), national instrument to fight disease which encompasses four dimensions: (a) management and governance, (b) surveillance, (c) comprehensive care, (d) strengthening educommunication. In dimension education, SNP developed learning pathway other Sexually Transmitted Infections (STIs)" strengthen...
Background: During the COVID-19 emergency, different vaccination strategies were developed to combat moderate or severe cases and avoid millions of deaths worldwide. Among vaccine protocols studied for COVID-19, Viana Project Study has demonstrated effectiveness primary with a half dose ChAdOx1 nCoV-19 preventing new in short-term follow-up. This study evaluates (HD) immunization protocol (up 2 doses) reducing cases, hospitalizations, when compared administration full doses (FD) after...
Previously, we presented the effectiveness of ChAdOx1 nCoV-19 half-dose (HD) immunization for preventing new COVID-19 cases. Here, evaluated administration an HD in primary protocol (up to two doses) reducing moderate and severe cases, hospitalizations, deaths when compared full doses (FD) after a long-term follow-up.We data from 29,469 participants between January 2021 November 2022 who received or FD vaccine crossed this information with their medical records identify those developed All...